Related references
Note: Only part of the references are listed.Direct Comparison of the Tau PET Tracers 18F-Flortaucipir and 18F-MK-6240 in Human Subjects
Alexandra Gogola et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Relationship between amyloid and tau levels and its impact on tau spreading
Vincent Dore et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET
Renaud La Joie et al.
NEUROLOGY (2021)
Tauvid (TM): The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease
Caitlin V. M. L. Jie et al.
PHARMACEUTICALS (2021)
Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease
Christopher Fowler et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2021)
Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease
Rik Ossenkoppele et al.
ALZHEIMERS & DEMENTIA (2020)
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease
Sanka Amadoru et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
Cinthya Aguero et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging
Arnaud Charil et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL
Pierrick Bourgeat et al.
NEUROIMAGE (2018)
The association between tau PET and retrospective cortical thinning in clinically normal elderly
Molly R. LaPoint et al.
NEUROIMAGE (2017)
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
Shannon L. Risacher et al.
NEUROLOGY (2017)
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
Chenjie Xia et al.
JAMA NEUROLOGY (2017)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
Samantha C. Burnham et al.
LANCET NEUROLOGY (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
Comparison of MR-less PiB SUVR quantification methods
Pierrick Bourgeat et al.
NEUROBIOLOGY OF AGING (2015)
Neuropathological subtypes of Alzheimer's disease
Kurt A. Jellinger
ACTA NEUROPATHOLOGICA (2012)
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Melissa E. Murray et al.
LANCET NEUROLOGY (2011)
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
Kathryn A. Ellis et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)